Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Leukemia

• Publication date

  2021-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41375-021-01383-2PMID 34389803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated B-type natriuretic peptide (BNP) and soluble thrombomodulin (sTM) indicates severity and poor prognosis of sepsis.

  2021cited by this paper
• Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

  2021cited by this paper
• Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study

  2021cited by this paper
• Application of serum markers in diagnosis and staging of ovarian endometriosis

  2021cited by this paper
• Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.

  2020cited by this paper
• Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian Children

  2020cited by this paper
• Effects of germline variants in DHFR and FPGS on methotrexate metabolism and relapse of leukemia.

  2020cited by this paper
• Evaluation of the Diagnostic and Prognostic Value of Syndecan-1 in Acute Leukemia Patients

  2020cited by this paper
• Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis

  2019cited by this paper
• Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.

  2019cited by this paper
• Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.

  2019cited by this paper
• Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.

  2019cited by this paper
• The glycocalyx: a novel diagnostic and therapeutic target in sepsis

  2019cited by this paper
• Soluble syndecans: biomarkers for diseases and therapeutic options

  2018cited by this paper
• Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

  2018cited by this paper
• Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation

  2018cited by this paper
• Mechanism and management of cancer-associated thrombosis.

  2018cited by this paper
• Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.

  2018cited by this paper
• Thrombosis in pediatric patients with leukemia.

  2018cited by this paper
• Endothelial Dysfunction and Venous Thrombosis

  2018cited by this paper
• Soluble Fms-Like Tyrosine Kinase-1 Is A Marker of Endothelial Dysfunction During Sepsis

  2018cited by this paper
• The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease

  2018cited by this paper
• Acute hyperglycemia exacerbates trauma-induced endothelial and glycocalyx injury: An in vitro model

  2018cited by this paper
• Role of Endothelial Cells in Acute and Chronic Thrombosis

  2018cited by this paper
• Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL2008

  2018cited by this paper
• Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations

  2018cited by this paper
• Targeting therapeutics to endothelium: are we there yet?

  2017cited by this paper
• Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia – a cohort study from the United Kingdom

  2017cited by this paper
• Toxicity profile and treatment delays in NOPHO ALL2008—comparing adults and children with Philadelphia chromosome‐negative acute lymphoblastic leukemia

  2016cited by this paper
• Asparaginase-associated toxicity in children with acute lymphoblastic leukemia

  2015cited by this paper
• Pegasparaginase treatment alters thrombin generation by modulating the protein C and S system in acute lymphoblastic leukaemia/lymphoma

  2015cited by this paper
• Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.

  2014cited by this paper
• Second-generation PLINK: rising to the challenge of larger and richer datasets

  2014cited by this paper
• The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

  2014cited by this paper
• Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia

  2014cited by this paper
• Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.

  2013cited by this paper
• The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia

  2013cited by this paper
• High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study

  2012cited by this paper
• Transitioning childhood cancer survivors to adult‐centered healthcare: insights from parents, adolescent, and young adult survivors

  2010cited by this paper
• Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors

  2010cited by this paper
• HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells.

  2010cited by this paper
• Systematic review on the effect of glucocorticoid use on procoagulant, anti‐coagulant and fibrinolytic factors

  2010cited by this paper
• Thrombomodulin and von Willebrand Factor: Relation to Endothelial Dysfunction and Disease Outcome in Children with Acute Lymphoblastic Leukemia

  2010cited by this paper
• A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use

  2009cited by this paper
• Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis*

  2008cited by this paper
• Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).

  2008cited by this paper
• L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia

  2008cited by this paper
• Prevalence of post‐thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia

  2008cited by this paper
• The endothelial glycocalyx: composition, functions, and visualization

  2007cited by this paper
• Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo.

  2006cited by this paper
• Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes

  2004cited by this paper
• Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia.

  2003cited by this paper
• Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

  2000cited by this paper
• Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.

  1999cited by this paper
• Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma.

  1998cited by this paper
• Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.

  1996cited by this paper
• Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase.

  1995cited by this paper
• Endothelial cell function and thrombosis.

  1994cited by this paper
• Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency.

  1994cited by this paper
• Endothelial cell function and thrombosis.

  1994cited by this paper
• Plasma thrombomodulin in health and diseases.

  1990cited by this paper
• Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation.

  1987cited by this paper
• Effect of corticosteroids on coagulation tests.

  1983cited by this paper
• Effect of corticosteroids on coagulation tests.

  1983cited by this paper
• The effect of L‐asparaginase on plasma coagulation factors in acute lymphoblastic leukemia

  1977cited by this paper
• The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.

  1977cited by this paper

• Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol

  2024cites this paper
• Effects of Hydroxytyrosol in Endothelial Functioning: A Comprehensive Review

  2023cites this paper
• Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers

  2023cites this paper
• Cancer associated thrombosis in pediatric patients.

  2022cites this paper
• Cerebral sinovenous thrombosis and asparaginase re‐exposure in patients aged 1–45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study

  2022cites this paper